Hepatitis B Vaccine Market Segmentation

By product type

• Monovalent Hepatitis B (HepB) vaccines
• Combination vaccines containing HepB, such as:
• Hexavalent (DTaP/DTwP + IPV + Hib + HepB)
• Pentavalent (DTwP + Hib + HepB)
• HepA–HepB combinations (travel/high-risk adult use)

By antigen / platform

• Recombinant HBsAg (standard modern platform)
• Adjuvanted recombinant (e.g., CpG-adjuvanted adult products)

By dosing regimen / schedule

• 2-dose adult schedules (where available/approved)
• 3-dose schedules (routine infant series; many adult regimens)
• Birth-dose (within 24 hours)

By age group

• Birth dose (newborn)
• Infants/children (routine immunization)
• Adolescents (catch-up / school programs)
• Adults
• General adult catch-up
• high-risk adults (healthcare workers, ESRD/dialysis, etc.)

By indication / use case

• Routine immunization (NIP / EPI)
• Catch-up vaccination
• Maternal/PMTCT-linked newborn protection (birth dose policies)
• Travel medicine / private market

By end user

• Public immunization programs
• Hospitals
• Clinics / physician offices
• Travel clinics
• Pharmacies (in some countries)

By distribution / procurement channel

• Government tenders / pooled procurement (UNICEF, PAHO, etc.)
• Private distributors / wholesalers
• Retail pharmacy channel (where allowed)

By presentation / packaging

• Single-dose vial / prefilled syringe
• Multi-dose vials (e.g., 10-dose)
• Other pack sizes used in public procurement

By geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa